DCR-PH1

DCR-PH1 · Dicerna Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DCR-PH1, covering 2024-07-11 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Extension Study in Patients With Primary Hyperoxaluria [Phase 3]